Dose-ranging study of riluzole in amyotrophic lateral sclerosisPhilippe Guillet, Lucette Lacomblez, Gilbert Bensimon et al.|The Lancet|1996Cited by 1.3k
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosisMichael A. van Es, Robert H. Brown, Ewout J. N. Groen et al.|Nature Genetics|2009Cited by 404
Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association studyAleksey Shatunov, Ammar Al‐Chalabi, Kin Y. Mok et al.|The Lancet Neurology|2010Cited by 226
Reduced expression of the <i>Kinesin-Associated Protein 3</i> ( <i>KIFAP3</i> ) gene increases survival in sporadic amyotrophic lateral sclerosisJohn E. Landers, Robert H. Brown, Judith Melki et al.|Proceedings of the National Academy of Sciences|2009Cited by 185
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2Ilaria Giovannelli, Janine Kirby, Nadhim Bayatti et al.|Brain Communications|2021Cited by 28